Neurofibromatosis type 1 revisited (Q37360771)

From Wikidata

Jump to navigation Jump to search

scientific article published on January 2009

Language	Label	Description	Also known as
English	Neurofibromatosis type 1 revisited	scientific article published on January 2009

Statements

scholarly article

1 reference

Europe PubMed Central

19 August 2017

1 reference

Europe PubMed Central

Neurofibromatosis type 1 revisited (English)

1 reference

Europe PubMed Central

19 August 2017

neurofibromatosis type I

0 references

author name string

Virginia C Williams

1

1 reference

Europe PubMed Central

19 August 2017

John Lucas

2

1 reference

Europe PubMed Central

19 August 2017

Michael A Babcock

3

1 reference

Europe PubMed Central

19 August 2017

David H Gutmann

4

1 reference

Europe PubMed Central

19 August 2017

Bruce Korf

5

1 reference

Europe PubMed Central

19 August 2017

Bernard L Maria

6

1 reference

Europe PubMed Central

19 August 2017

language of work or name

0 references

publication date

1 January 2009

1 reference

Europe PubMed Central

19 August 2017

1 reference

Europe PubMed Central

19 August 2017

123

1 reference

Europe PubMed Central

19 August 2017

124-133

1 reference

Europe PubMed Central

19 August 2017

1

1 reference

Europe PubMed Central

19 August 2017

Neurofibromatosis type 1 and sporadic optic gliomas.

1 reference

https://www.researchgate.net/publication/23715072_Neurofibromatosis_Type_1_Revisited#references

(PDF) Neurofibromatosis Type 1 Revisited (English)

Neurofibromatosis 1: clinical manifestations and diagnostic criteria

1 reference

https://www.researchgate.net/publication/23715072_Neurofibromatosis_Type_1_Revisited#references

(PDF) Neurofibromatosis Type 1 Revisited (English)

Associations of osseous abnormalities in Neurofibromatosis 1.

1 reference

https://www.researchgate.net/publication/23715072_Neurofibromatosis_Type_1_Revisited#references

(PDF) Neurofibromatosis Type 1 Revisited (English)

Carboplatin and vincristine chemotherapy for children with newly diagnosed progressive low-grade gliomas.

1 reference

https://www.researchgate.net/publication/23715072_Neurofibromatosis_Type_1_Revisited#references

(PDF) Neurofibromatosis Type 1 Revisited (English)

Hereditary spinal neurofibromatosis: a rare form of NF1?

1 reference

https://www.researchgate.net/publication/23715072_Neurofibromatosis_Type_1_Revisited#references

(PDF) Neurofibromatosis Type 1 Revisited (English)

Tumorigenic properties of neurofibromin-deficient neurofibroma Schwann cells

1 reference

https://www.researchgate.net/publication/23715072_Neurofibromatosis_Type_1_Revisited#references

(PDF) Neurofibromatosis Type 1 Revisited (English)

Cardiovascular disease in neurofibromatosis 1: report of the NF1 Cardiovascular Task Force

1 reference

https://www.researchgate.net/publication/23715072_Neurofibromatosis_Type_1_Revisited#references

(PDF) Neurofibromatosis Type 1 Revisited (English)

Phase I study of thalidomide for the treatment of plexiform neurofibroma in neurofibromatosis 1.

1 reference

https://www.researchgate.net/publication/23715072_Neurofibromatosis_Type_1_Revisited#references

(PDF) Neurofibromatosis Type 1 Revisited (English)

Neurofibromatosis type I tumor suppressor neurofibromin regulates neuronal differentiation via its GTPase-activating protein function toward Ras.

1 reference

https://www.researchgate.net/publication/23715072_Neurofibromatosis_Type_1_Revisited#references

(PDF) Neurofibromatosis Type 1 Revisited (English)

Survival of Human Neurofibroma in Immunodeficient Mice and Initial Results of Therapy With Pirfenidone

1 reference

https://www.researchgate.net/publication/23715072_Neurofibromatosis_Type_1_Revisited#references

(PDF) Neurofibromatosis Type 1 Revisited (English)

Neurofibromatous neuropathy in neurofibromatosis 1 (NF1).

1 reference

https://www.researchgate.net/publication/23715072_Neurofibromatosis_Type_1_Revisited#references

(PDF) Neurofibromatosis Type 1 Revisited (English)

Spontaneous involution of a non-optic astrocytoma in neurofibromatosis type I: serial magnetic resonance imaging evaluation.

1 reference

https://www.researchgate.net/publication/23715072_Neurofibromatosis_Type_1_Revisited#references

(PDF) Neurofibromatosis Type 1 Revisited (English)

Resection of small plexiform neurofibromas in neurofibromatosis type 1 children

1 reference

https://www.researchgate.net/publication/23715072_Neurofibromatosis_Type_1_Revisited#references

(PDF) Neurofibromatosis Type 1 Revisited (English)

The nature and frequency of cognitive deficits in children with neurofibromatosis type 1.

1 reference

https://www.researchgate.net/publication/23715072_Neurofibromatosis_Type_1_Revisited#references

(PDF) Neurofibromatosis Type 1 Revisited (English)

The HMG-CoA reductase inhibitor lovastatin reverses the learning and attention deficits in a mouse model of neurofibromatosis type 1

1 reference

https://www.researchgate.net/publication/23715072_Neurofibromatosis_Type_1_Revisited#references

(PDF) Neurofibromatosis Type 1 Revisited (English)

Guidelines for the diagnosis and management of individuals with neurofibromatosis 1

1 reference

https://www.researchgate.net/publication/23715072_Neurofibromatosis_Type_1_Revisited#references

(PDF) Neurofibromatosis Type 1 Revisited (English)

Tumor microenvironment and neurofibromatosis type I: connecting the GAPs

1 reference

https://www.researchgate.net/publication/23715072_Neurofibromatosis_Type_1_Revisited#references

(PDF) Neurofibromatosis Type 1 Revisited (English)

Bone mineral density in children and adolescents with neurofibromatosis type 1.

1 reference

https://www.researchgate.net/publication/23715072_Neurofibromatosis_Type_1_Revisited#references

(PDF) Neurofibromatosis Type 1 Revisited (English)

NF1 plexiform neurofibroma growth rate by volumetric MRI: relationship to age and body weight.

1 reference

https://www.researchgate.net/publication/23715072_Neurofibromatosis_Type_1_Revisited#references

(PDF) Neurofibromatosis Type 1 Revisited (English)

AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients.

1 reference

https://www.researchgate.net/publication/23715072_Neurofibromatosis_Type_1_Revisited#references

(PDF) Neurofibromatosis Type 1 Revisited (English)

Germline loss-of-function mutations in SPRED1 cause a neurofibromatosis 1-like phenotype

1 reference

https://www.researchgate.net/publication/23715072_Neurofibromatosis_Type_1_Revisited#references

(PDF) Neurofibromatosis Type 1 Revisited (English)

Vascular abnormalities in patients with neurofibromatosis syndrome type I: clinical spectrum, management, and results

1 reference

https://www.researchgate.net/publication/23715072_Neurofibromatosis_Type_1_Revisited#references

(PDF) Neurofibromatosis Type 1 Revisited (English)

[18F]2-fluoro-2-deoxy-D-glucose positron emission tomography (FDG PET) as a diagnostic tool for neurofibromatosis 1 (NF1) associated malignant peripheral nerve sheath tumours (MPNSTs): a long-term clinical study

1 reference

https://www.researchgate.net/publication/23715072_Neurofibromatosis_Type_1_Revisited#references

(PDF) Neurofibromatosis Type 1 Revisited (English)

Identifiers

10.1542/PEDS.2007-3204

1 reference

Europe PubMed Central

19 August 2017

1 reference

Europe PubMed Central

19 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37360771&oldid=1890679652"